Trifluoroacetic acid → 4-(4-fluoroquinolin-2-yl)-N-methylaniline
반응식
[F:1][C:2]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[N:5]=[C:4]([C:12]2[CH:17]=[CH:16][C:15]([N:18](C)[C:19](=O)OC(C)(C)C)=[CH:14][CH:13]=2)[CH:3]=1.C(O)(C(F)(F)F)=O>>[F:1][C:2]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[N:5]=[C:4]([C:12]2[CH:17]=[CH:16][C:15]([NH:18][CH3:19])=[CH:14][CH:13]=2)[CH:3]=1참가 물질
3
실험 절차
tert-Butyl (4-(4-fluoroquinolin-2-yl)phenyl)(methyl)carbamate (4.5 mg, 0.013 mmol) was treated with TFA by using general procedure P. The crude product was purified by HPLC to afford T466 as an orange-colored solid (1.8 mg, 55%). 1H NMR (400 MHz, CDCl3): δ 8.57 (d, J=8.4 Hz, 1H), 8.02-7.97 (m, 3H), 7.75 (t, J=7.6 Hz, 1H), 7.56 (d, J=10.0 Hz, 1H), 6.72 (d, J=8.4 Hz, 2H), 2.95 (s, 3H); MS (ESI): 253 (M+H+).
후처리
- customThe crude product was purified by HPLC